Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00990 |
| Species: | Homo sapiens |
| Position : | chr2:239866844-239871938 |
| Year: | 2025 |
| Title: | Genomic Locus Tagged by Lung Function GWAS SNV rs12477314 (2q373) Acts as a Regulatory Region for a Systemic Inflammatory Phenotype |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | bladder carcinoma |
| PMID: | 40512334 |
| MONDO: | MONDO:0005094 |
| Tissue: | Bladder |
| Tissue Ontology ID: | UBERON:0001255 |
| Cell Source: | SVHUC-1 |
| CVCL ID: | CVCL_6903 |
| Cell Type: | bladder epithelial cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | PER2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01287 | chr2:239866844-239871938 | Lung | non-small cell lung carcinoma cell | non-small cell lung carcinoma |